Advertisement

Bioterrorism Alert for Health Care Workers

  • Theodore J. Cieslak
  • George W. Christopher
  • Edward M. EitzenJr.
Part of the Emerging Infectious Diseases of the 21st Century book series (EIDC)

Abstract

When the agent used in a biological attack is known, response to such an attack is considerably simplified. The first eight chapters of this text deal with agent-specific concerns and strategies for dealing with infections due to the intentional release of these agents. A larger problem arises when the identity of an agent is not known. In fact, in some cases, an attack may be threatened or suspected, but it may remain unclear as to whether such an attack has actually occurred. Moreover, it may be unclear whether casualties are due to a biological agent, a chemical agent, or even a naturally occurring infectious disease process or toxic exposure. Recent experience with West Nile Virus (Fine and Layton, 2001), Severe Acute Respiratory Syndrome (SARS) (Lampton, 2003), and monkeypox highlight this dilemma. In each of these cases, the possibility of bioterrorism was raised, and rightly so, although each outbreak ultimately proved to have a natural origin. This chapter provides a framework for dealing with outbreaks of unknown origin and etiology. Furthermore, it addresses several related concerns and topics not covered elsewhere in this text.

Keywords

West Nile Virus Severe Acute Respiratory Syndrome Severe Acute Respiratory Syndrome Public Health Authority Mass Vaccination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgments

The opinions and assertions contained herein are the private views of the authors and are not to be construed as official or as necessarily reflecting the views of the U.S. Department of Defense, the U.S. Department of Health and Human Services, or their component services, agencies, and institutions.

References

  1. Amorosa, V.K., and Isaacs, S.N. (2003). Separate worlds set to collide: smallpox, vaccinia virus vaccination, and human immunodeficiency virus and acquired immunodeficiency syndrome. Clin. Infect. Dis. 37:4267–432.Google Scholar
  2. Blank, S., Moskin, L.C., and Zucker, J.R. (2003). An ounce of prevention is a ton of work: mass antibiotic prophylaxis for anthrax, New York City, 2001. Emerg. Infect. Dis. 9:615–622.PubMedCrossRefGoogle Scholar
  3. Bozzette, S.A., Boer, R., Bhatnagar, V., Brower, L.J., Keeler, E.B., Morton, S.C., and Stoto, M.A. (2003). A model for smallpox-vaccination policy. N. Engl. J. Med. 348:416–425.PubMedCrossRefGoogle Scholar
  4. Brachman, P.S., Gold, H., Plotkin, S.A., Fekerty, F.R., Werrin, M., and Ingraham, N.R. (1962). Field evaluation of a human anthrax vaccine. Am. J. Public Health 52:632–645.CrossRefGoogle Scholar
  5. Centers for Disease Control and Prevention. (1998). Investigating an outbreak. In: Principles of Epidemiology: Self Study Course SS3030, 2nd ed. Centers for Disease Control and Prevention, Atlanta, pp. 347–424.Google Scholar
  6. Centers for Disease Control and Prevention. (1999). Bioterrorism alleging use of anthrax and interim guidelines for management- United States, 1998. MMWR. Morb. Mortal. Wkly. Rep. 48:697–74.Google Scholar
  7. Centers for Disease Control and Prevention. (2000). Biological and chemical terrorism: strategic plan for preparedness and response. MMWR. Morb. Mortal. Wkly. Rep. 49(RR-04):1–14.Google Scholar
  8. Centers for Disease Control and Prevention. (2002). Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the advisory committee on immunization practices. MMWR. Morb. Mortal. Wkly. Rep. 51:1024–1026.Google Scholar
  9. Centers for Disease Control and Prevention. (2003a). Smallpox vaccination and adverse reactions: guidance for clinicians. MMWR. Morb. Mortal. Wkly. Rep. 52(Dispatch):1–29.Google Scholar
  10. Centers for Disease Control and Prevention. (2003b). Recommendations for using smallpox vaccine in a pre-event vaccination program. MMWR. Morb. Mortal. Wkly. Rep. 52(RR-07):1–16.Google Scholar
  11. Centers for Disease Control and Prevention. (2003c). Update: cardiac and other adverse events following civilian smallpox vaccination—United States. MMWR. Morb. Mortal. Wkly. Rep. 52:639–642.Google Scholar
  12. Centers for Disease Control and Prevention. (2003d). Update: Adverse events following civilan smallpox vaccination—United States, 2003. MMWR. Morb. Mortal. Wkly. Rep. 52:819–820.Google Scholar
  13. Centers for Disease Control and Prevention. (2003e). Smallpox response plan and guidelines (version 3.0). Accessed August 19, 2003. Available at: http://www.bt.cdc.gov/agent/smallpox/response-plan/index.asp.
  14. Centers for Disease Control and Prevention. (2003f). Public health emergency preparedness and response. Accessed 31 August 2003. Available at: http://www.cdc.bt.gov.
  15. Cieslak T.J., Christopher, G.W., Kortepeter. M.G., Rowe, J.R., Pavlin, J.A., Culpepper, R.C., and Eitzen, E.M. (2000). Immunization against potential biological warfare agents. Clin. Infect. Dis., 30:843–850.PubMedCrossRefGoogle Scholar
  16. Cieslak, T.J., and Henretig, F.M. (2001). Medical consequences of biological warfare: the ten commandments of management. Milit. Med. 166(Suppl 2):11–12.Google Scholar
  17. Cieslak, T.J., and Henretig, F.M. (2003a). Bioterrorism. Pediatr. Ann. 32:154–165.PubMedGoogle Scholar
  18. Cieslak, T.J., and Henretig, F.M. (2003b). Biological and chemical terrorism. In: Berman, R.E., Kliegman, R.M., and Jenson, H.B. (eds.), Nelson Textbook of Pediatrics, 17th ed. Saunders, Philadelphia, pp. 2378–2385.Google Scholar
  19. Cieslak, T.J., Kortepeter, M.G., and Eitzen, EM. (2004). Vaccines against agents of bioterrorism. In: Levine, M.M., Kaper, J.B., Rappouli, R., Liu, M., and Good, MF. (eds.), New Generation Vaccines, 3rd ed. Marcel Dekker, New York.Google Scholar
  20. Cieslak, T.J., Rowe, J.R., Kortepeter, M.G., Madsen, J.M., Newmark, J., Christopher, G.W., Culpep-per, R.C., and Eitzen, E.M. (2000). A field-expedient algorithmic approach to the clinical management of chemical and biological casualties. Milit. Med. 165:659–662.Google Scholar
  21. Cole, L.A. (2000). Bioterrorism threats: learning from inappropriate responses. J. Public Health Manag. Pract.6:8–18.PubMedGoogle Scholar
  22. Committee on Trauma, American College of Surgeons. (1989). Initial assessment and management. In: Advanced Trauma Life Support Student Manual. American College of Surgeons, Chicago, pp. 9–30.Google Scholar
  23. Emergency Management Institute. (1998). Incident Command System Independent Study Guide -(IS-195). Federal Emergency Management Agency, Washington, D.C.Google Scholar
  24. Esbitt, D. (2003). The Strategic National Stockpile: roles and responsibilities of health care professionals for receiving the stockpile assets. Disaster Manag. Response. 1:68–70.PubMedCrossRefGoogle Scholar
  25. Fauci, A.S. (2002). Smallpox vaccination policy-the need for dialogue. N. Engl. J. Med. 346:1319–1320.PubMedGoogle Scholar
  26. Federal Emergency Management Agency. (2003). The Federal Response Plan (9230.1PL, interim). U.S. Government Printing Office, Washington, D.C.Google Scholar
  27. Ferguson, N.E., Steele, L., Crawford, C.Y., Huebner, N.L., Fonseka, J.C., Bonander, J.C., and Kuehnert, M.J. (2003). Bioterrorism web site resources for infectious disease clinicians and epidemiologists. Clin. Infect. Dis. 36:1458–1473.PubMedCrossRefGoogle Scholar
  28. Fine, A., and Layton, M. (2001). Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. Clin. Infect. Dis. 32:277–282.PubMedCrossRefGoogle Scholar
  29. Garner, J.S., and The Hospital Infection Control Practices Advisory Committee (1996). Guideline for infection precautions in hospitals. Infect. Control. Hosp. Epidemiol. 17:53–80.PubMedCrossRefGoogle Scholar
  30. Gilchrist, M.J.R. (2000). A national laboratory network for bioterrorism: evolution from a prototype network of laboratories performing routine surveillance. Milit. Med. 165(Suppl 2):28–31.Google Scholar
  31. Grabenstein, J.D., and Winkenwerder, W., Jr. (2003). US military smallpox vaccination experience. J.A.M.A. 289;3278–3282.PubMedCrossRefGoogle Scholar
  32. Halsell, J.S., Riddle, J.R., Atwood, J.E., Gardner, P., Shope, R., Poland, G.A., Gray, G.C., Ostroff, S., Eckart, R.E., Hospenthal, D.R., Gibson, R.L., Grabenstein, J.D., Arness, M.K., Tornberg, D.N., and Department of Defense Smallpox Vaccination Clinical Evaluation Team. (2003). Myoperi-carditis following smallpox vaccination among vaccinia-naive US military personnel. J.A.M.A. 289:328–3289.CrossRefGoogle Scholar
  33. Health Resources and Services Administration, Department of Health and Human Services. (2003). Smallpox vaccine injury compensation program: smallpox (vaccinia) vaccine injury table. Fed Reg. 68:51492–51499.Google Scholar
  34. Henretig, F.M., Cieslak, T.J., Kortepeter, M.G., and Fleisher, G.R. (2002). Medical management of the suspected victim of bioterrorism: an algorithmic approach to the undifferentiated patient. Emerg. Med. Clin. North Am. 20:351–364.PubMedCrossRefGoogle Scholar
  35. Hiss, J., and Arensburg, B. (1992). Suffocation from misuse of gas masks during the Gulf War. Br. Med. J. 304:92.CrossRefGoogle Scholar
  36. Holloway, H.L., Norwood, A.E., Fullerton, C.S., Engel, C.C., and Ursano, R.J. (1997). The threat of biological weapons: prophylaxis and mitigation of psychological and social consequences. J.A.M.A. 278:425–427.PubMedCrossRefGoogle Scholar
  37. Joint Commission on Accreditation of Healthcare Organizations. (2003). Hospital Accreditation Standards. JCAHO, Oakbrook Terrace, Illinois, pp. 221–224.Google Scholar
  38. Kaplan, E.H., Craft, D.L., and Wein, L.M. (2002). Emergency response to a smallpox attack: the case for mass vaccination. Proc. Natl. Acad. Sci. U.S.A. 99:10935–10940.PubMedCrossRefGoogle Scholar
  39. Kemper, A.R., Davis, M.M., and Freed, G.L. (2002). Expected adverse events in a mass smallpox vaccination campaign. Eff. Clin. Pract. 5:84–90.PubMedGoogle Scholar
  40. Knouss, R.F. (2001). National disaster medical system. Public Health Rep. 116(Suppl 2):49–52.PubMedCrossRefGoogle Scholar
  41. Kortepeter, M.G., and Cieslak, T.J. (2003). Bioterrorism: plague, anthrax, and smallpox. In: Baddour, L., and Gorbach, S.L. (eds.), Therapy of Infectious Diseases. W.B. Saunders, Philadelphia, pp. 723–740.Google Scholar
  42. Lampton, L.M. (2003). SARS, biological terrorism, and mother nature. J. Miss. State Med. Assoc. 44:151–152.PubMedGoogle Scholar
  43. Mack, T. (2003). A different view of smallpox and vaccination. N. Engl.J. Med. 348:460–463.PubMedCrossRefGoogle Scholar
  44. Morse, S.A., Kellogg, R.B., Perry, S., Meyer, R.F., Bray, D., Nichelson, D., and Miller, J.M. (2003). Detecting biothreat agents: the laboratory response network. ASM News. 69:433–437.Google Scholar
  45. Mortimer, P.P. (2003). Can postexposure vaccination against smallpox succeed? Clin. Infect. Dis. 36:622–629.PubMedCrossRefGoogle Scholar
  46. Pavlin, J.A. (1999). Epidemiology of bioterrorism. Emerg. Infect. Dis. 5:528–530.PubMedCrossRefGoogle Scholar
  47. Rundell, J.R. (2003). A consultation-laison psychiatry approach to disaster/terrorism victim assessment and management. In: Ursano, R.J., Fullerton, A.E., and Norwood, C.S. (Eds.), Terrorism and Disaster: Individual and Community Mental Health Interventions. Cambridge University Press, New York, pp. 107–120.Google Scholar
  48. U.S. Army Medical Research Institute of Infectious Diseases. (2000). Medical management of biological warfare casualties CD-ROM: U.S. Army Medical Research Institute of Infectious Diseases, Ft. Detrick, MD.Google Scholar
  49. U.S. Army Medical Research Institute of Infectious Diseases, U.S. Food and Drug Administration. (2000). Biological warfare and terrorism: medical issues and response [satellite television broadcast]. U.S. Army Medical Research Institute of Infectious Diseases, U.S. Food and Drug Administration, Gaithersburg, MD.Google Scholar
  50. U.S. Department of Health and Human Services. (1999). Biosafety in Microbiological and Biomedical Laboratories, 4th ed. U.S. Government Printing Office, Washington, D.C.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Theodore J. Cieslak
    • 1
  • George W. Christopher
    • 2
  • Edward M. EitzenJr.
    • 3
  1. 1.San Antonio Military Pediatric CenterSan AntonioTX
  2. 2.Wilford Hall Air Force Medical Center, Lackland Air Force Base
  3. 3.Department of Health and Human ServicesWashingtonDC

Personalised recommendations